Gland Pharma soars on getting EIR from USFDA for Visakhapatnam facility

Gland Pharma trades higher on getting USFDA’s approval for Sugammadex Injection

Gland Pharma is currently trading at Rs. 1780.00, up by 36.20 points or 2.08% from its previous closing of Rs. 1743.80 on the BSE. The scrip opened at Rs. 1587.55 and has touched a high and low of Rs. 1800.00 and Rs. 1587.55 respectively. So far 3074 shares were traded on the counter. The BSE … Read more

LPG Users Alert: Complete eKYC by August 16 Magic Photo Editor drops ₹12,579 before Pixel 11 launch! Jio’s Best Offer: Free WiFi for 1 Month, 100Mbps Internet!